AI Analysis of 400,000 Reddit Posts Uncovers Underreported GLP-1 Side Effects

Penn researchers use AI to find underreported GLP-1 side effects like reproductive issues and temperature changes in massive Reddit data analysis.

By: AXL Media

Published: Apr 11, 2026, 6:48 AM EDT

Source: Information for this report was sourced from Penn Engineering, Nature Health, and Scienmag.

Mining Social Media for Real-World Clinical Insights

A large-scale "computational social listening" project has revealed that patients taking semaglutide and tirzepatide may be experiencing systemic side effects not fully captured during standard regulatory trials. By deploying large language models to parse through 410,198 Reddit posts spanning over five years, the research team identified nearly 70,000 unique users sharing their personal medical journeys. This AI-driven approach allowed researchers to map informal patient language to the standardized Medical Dictionary for Regulatory Activities (MedDRA), bridging the gap between anecdotal "neighborhood grapevine" discussions and formal clinical terminology.

Reproductive and Hormonal Irregularities Flagged

One of the most striking findings from the study involves the prevalence of reproductive symptoms, which are currently underrepresented in drug labeling. Approximately 4% of the analyzed Reddit users reported menstrual irregularities, including intermenstrual bleeding, erratic cycles, and unusually heavy flows. According to Dr. Jena Shaw Tronieri, a co-author from Penn’s Center for Weight and Eating Disorders, these drugs interact with the hypothalamus—a brain region critical for hormonal regulation—suggesting that the observed reproductive shifts warrant immediate and systematic clinical investigation.

Thermal Dysregulation and Persistent Fatigue

Beyond hormonal concerns, the AI analysis highlighted a significant cluster of temperature-related complaints among GLP-1 users. Many patients reported experiencing chills, hot flashes, and fever-like symptoms that were not frequently documented in the primary clinical trials for these medications. Additionally, fatigue emerged as the second most common complaint in the online dataset. While fatigue is noted in some official reports, its overwhelming frequency on social media suggests it may be a more pervasive and concerning symptom for the general population than previously realized.